GlassScriptPhysician profile
Brenda O Onia
NPI 1710936687
$6,141.41
in general payments reported to CMS, 2019-2025
40 companies · $722 in 2025
The $722 reported for 2025 was more than what 87% of Obstetrics & Gynecology providers received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $845 · 2020: $161 · 2021: $880 · 2022: $1,488 · 2023: $1,134 · 2024: $912 · 2025: $722.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,767.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,767.48 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $1,429.06 | 2019-2025 | |
| Organon LLC | $416.00 | 2022-2025 | Nexplanon, Nuvaring, Jada System |
| Coopersurgical, INC. | $378.91 | 2019-2025 | Paragard T 380a, Paragard T 380a, Endosee |
| Exeltis, USA INC. | $359.93 | 2019-2025 | Slynd |
| Mayne Pharma Commercial LLC | $345.23 | 2021-2025 | |
| Agile Therapeutics, INC. | $306.18 | 2021-2024 | Twirla |
| Avion Pharmaceuticals | $262.24 | 2019-2023 | Balcoltra |
| Mylan Pharmaceuticals INC. | $222.33 | 2021-2022 | |
| Hologic Sales and Service, LLC | $209.54 | 2019-2025 | Aptima, Thinprep 2000 Processor, Myosure Tissue Removal Device |
| Bayer Healthcare Pharmaceuticals INC. | $178.55 | 2019-2025 | |
| Shield Therapeutics INC | $174.01 | 2023-2024 | Accrufer |
| Pfizer INC. | $149.82 | 2023-2025 | |
| Merck Sharp & Dohme LLC | $148.54 | 2019-2024 | Gardasil 9, Gardasil |
| Myriad Women'S Health, INC. | $122.25 | 2023 | Myrisk |
| Myovant Sciences INC. | $117.97 | 2022 |
Show all 40 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Exact Sciences Corporation | $104.99 | 2024-2025 | Cologuard Collection Kit, The Cologuard Plus Collection Kit |
| Therapeuticsmd, INC. | $103.52 | 2019-2021 | |
| Astellas Pharma US INC | $100.43 | 2024-2025 | Veozah |
| Medtronic, INC. | $84.87 | 2023 | Truclear |
| Allergan, INC. | $84.09 | 2019-2020 | |
| Amag Pharmaceuticals, INC. | $75.05 | 2019-2020 | |
| Biogen, INC. | $67.36 | 2025 | Zurzuvae |
| Seqirus USA INC | $62.48 | 2024-2025 | Flucelvax, Fluad |
| Evofem Biosciences, INC. | $61.89 | 2021 | |
| Becton, Dickinson and Company | $58.95 | 2022-2023 | Bd Onclarity |
| Amgen INC. | $57.60 | 2024 | Prolia, Evenity |
| Vertical Pharmaceuticals, LLC | $52.11 | 2019 | |
| Dysis Medical, INC. | $49.13 | 2019-2022 | |
| Aspira Women'S Health INC | $48.30 | 2021-2022 | |
| Lupin INC. | $47.45 | 2019 | |
| Millicent US INC | $38.55 | 2024-2025 | Intrarosa, Femring |
| Mission Pharmacal Company | $36.86 | 2019 | |
| Dexcom, INC. | $34.46 | 2025 | Dexcom G6 Transmitter |
| Boston Scientific Corporation | $29.92 | 2019 | |
| Sumitomo Pharma America, INC. | $26.93 | 2023 | Myfembree |
| Novo Nordisk INC | $22.52 | 2025 | Wegovy |
| Channel Medsystems, INC. | $21.10 | 2022 | |
| Gynesonics, INC. | $19.81 | 2023 | Sonata Sonography-Guided Transcervical Fibroid Ablation System |
| Monaghan Medical Corporation | $16.96 | 2023 | Aerochamber |
| Biohaven Pharmaceuticals, INC. | $15.52 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Brenda Onia listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.